We are live on ! Find out more
RA

Rise Advisors Portfolio holdings

AUM $355M
1-Year Est. Return 20.51%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+20.51%
3 Year Est. Return
+58.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$279M
AUM Growth
+$27M
Cap. Flow
+$12.3M
Cap. Flow %
4.42%
Top 10 Hldgs %
64.18%
Holding
1,624
New
86
Increased
635
Reduced
143
Closed
98

Top Buys

Rank Stock Value
1
VCRB icon
Vanguard Core Bond ETF
VCRB
+$17.2M
2
JSMD icon
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
+$13.6M
3
FBND icon
Fidelity Total Bond ETF
FBND
+$12.9M
4
VTV icon
Vanguard Value ETF
VTV
+$2.66M
5
VUG icon
Vanguard Growth ETF
VUG
+$2.43M

Top Sells

Rank Stock Value
1
DFCF icon
Dimensional Core Fixed Income ETF
DFCF
+$26.9M
2
DFAT icon
Dimensional US Targeted Value ETF
DFAT
+$13.3M
3
C icon
Citigroup
C
+$661K
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$602K
5
MU icon
Micron Technology
MU
+$247K

Sector Composition

Rank Sector Weight
1 Technology 8.6%
2 Financials 5.25%
3 Consumer Discretionary 3.25%
4 Industrials 2.89%
5 Healthcare 2.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DH icon
1326
Definitive Healthcare
DH
$71.1M
$702 ﹤0.01%
173
– –
VSH icon
1327
Vishay Intertechnology
VSH
$5.7B
$702 ﹤0.01%
46
-51
-53% -$809
LENZ
1328
LENZ Therapeutics
LENZ
$179M
$699 ﹤0.01%
+15
New +$552
SNA icon
1329
Snap-on
SNA
$21.1B
$693 ﹤0.01%
2
-2
-50% -$655
ORKA
1330
Oruka Therapeutics
ORKA
$5.44B
$692 ﹤0.01%
+36
New +$534
COHU icon
1331
Cohu
COHU
$2.26B
$691 ﹤0.01%
34
– –
ANVS icon
1332
Annovis Bio
ANVS
$71M
$689 ﹤0.01%
333
– –
LNC icon
1333
Lincoln National
LNC
$7.88B
$686 ﹤0.01%
17
– –
TYRA icon
1334
Tyra Biosciences
TYRA
$1.85B
$686 ﹤0.01%
+49
New +$559
EYPT icon
1335
EyePoint Inc
EYPT
$1.04B
$684 ﹤0.01%
+48
New +$553
MED icon
1336
Medifast
MED
$110M
$684 ﹤0.01%
50
– –
LMB icon
1337
Limbach Holdings
LMB
$886M
$680 ﹤0.01%
7
– –
TBBK icon
1338
The Bancorp
TBBK
$2.81B
$674 ﹤0.01%
9
– –
MTCH icon
1339
Match Group
MTCH
$9.05B
$671 ﹤0.01%
19
– –
STRO icon
1340
Sutro Biopharma
STRO
$398M
$668 ﹤0.01%
77
– –
MPTI icon
1341
M-tron Industries
MPTI
$369M
$666 ﹤0.01%
+12
New +$538
PNR icon
1342
Pentair
PNR
$10.2B
$665 ﹤0.01%
6
– –
CHRW icon
1343
C.H. Robinson
CHRW
$20.6B
$662 ﹤0.01%
+5
New +$587
GEVO icon
1344
Gevo
GEVO
$380M
$662 ﹤0.01%
+338
New +$551
EXPD icon
1345
Expeditors International
EXPD
$22.4B
$656 ﹤0.01%
5
+4
+400% +$476
TPC
1346
Tutor Perini Cor
TPC
$4.51B
$656 ﹤0.01%
+10
New +$557
CUBI icon
1347
Customers Bancorp
CUBI
$2.66B
$654 ﹤0.01%
10
– –
IDYA icon
1348
IDEAYA Biosciences
IDYA
$3.54B
$653 ﹤0.01%
24
– –
FHI icon
1349
Federated Hermes
FHI
$4.5B
$651 ﹤0.01%
13
+10
+333% +$507
IEX icon
1350
IDEX
IEX
$16.6B
$651 ﹤0.01%
4
– –
52 53
54
55 56

Similar funds

WKWM
Walter & Keenan Wealth Management Souh Bend, Indiana $355M AUM 23.15% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
CYG
Clean Yield Group Norwich, Vermont $355M AUM 19.69% 1-Year Est. Return
SWM
Seaside Wealth Management Carlsbad, California $356M AUM 18.53% 1-Year Est. Return
PWAC
Private Wealth Advisors (California) Fresno, California $356M AUM 26.22% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
HC
Headland Capital Mt. Pleasant, South Carolina $355M AUM 15.23% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return

Rise Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Rise Advisors held 1,624 positions worth $279M, up 11% from $252M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Rise Advisors deployed $12.3M of net new capital in Q3 2025, opening 86 new positions and adding to 635 existing holdings. Its largest new stake was Vanguard Core Bond ETF: 222,133 shares worth $17.4M.

By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional Core Fixed Income ETF, an estimated $26.9M trimmed.

  • Rise Advisors's largest Q3 2025 buy was Vanguard Core Bond ETF: 222,133 shares worth $17.4M.
  • Rise Advisors added most to Fidelity Total Bond ETF in Q3 2025, an estimated $12.9M increase.
  • Rise Advisors's biggest Q3 2025 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $26.9M.
  • Rise Advisors fully exited iShares Core Dividend Growth ETF in Q3 2025, selling an estimated $28.6K.
  • Rise Advisors's ten largest holdings make up 64% of its $279M portfolio in Q3 2025.
  • Rise Advisors opened 86 new positions and closed 98 in Q3 2025.
  • Rise Advisors's portfolio value rose 11% quarter-over-quarter to $279M.

Based on Rise Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.